Gene Query: TMED10

Dataset Description Geneva Score
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 114.58
RNA-seq analysis of BAP1-depleted uveal melanoma cells 89.53
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 50.11
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 40.01
EP400 is required for Max and MCPyV mediated gene activation 36.62
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 35.83
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 33.53
NRDE2 negatively regulates nuclear exosome functions 33.11
Co-transcriptional loading of RNA export factors shapes the human transcriptome 32.34
RNAseq of HEK293 cells after Chtop knockdown 32.34
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 31.8
Sensing self and nonself circular RNAs 30.4
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 28.67
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 24.16
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 23.2
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 22.78
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 22.26
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 22.26
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 21.98
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 21.72
Genetic-to-epigenetic Therapy for Pancreatic Cancer 20.75
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 20.22
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 18.12
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 17.97
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 17.97
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 17.82
Regulation of highly expressed hCINAP on translatome 17.76
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 17.28
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 17.28
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 17.25
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 17.23
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 16.9
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 16.79
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 16.76
Ribosomal footprinting of CN34-Parental and CN34-LM1a 16.55
Ribosomal footprinting of MDA-Parental and MDA-LM2 16.53
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 16.16
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 15.84
RNA-seq analysis of AML cells in response to ASLAN003 15.82
3’ Uridylation Expands miRNA Target Repertoire 15.81
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 15.66
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 15.62
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 15.28
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 15.26
Transcriptome-wide modulation of splicing by the exon junction complex 15.25
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 15.09
Solid phase chemistry to covalently and reversibly capture thiolated RNA 15.03
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 14.92
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 14.62
An optimization system for isolating and sequencing of single human colon cancer cells 14.55
Role of microRNAs in the interaction between Salmonella and the host cell 14.48
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 14.47
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 14.44
Cleavage Factor Im as a key regulator of 3’ UTR length 14.42
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 14.27
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 14.27
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 14.25
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 14.25
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 13.75
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 13.67
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 13.57
Pharmacologic inhibition of STAT5 in AML 13.56
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 13.44
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 13.41
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 13.41
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 13.4
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 13.24
Mitochondrial dsRNA triggers antiviral signalling in humans 13.17
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 13.1
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 13.1
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 13.1
Modeling Familial Cancer with iPSC Approaches 12.91
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 12.9
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 12.77
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 12.67
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 12.66
RNA transcriptome analysis during HSV-1 infection 12.35
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 12.26
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 12.15
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 11.94
Exploring the RNA landscape of endothelial exosomes 11.87
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 11.86
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 11.83
An RNA-centric dissection of host complexes controlling flavivirus infection 11.79
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 11.79
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 11.72
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 11.71
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 11.56
The human blood-nerve barrier transcriptome 11.34
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 11.15
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 11.15
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 11.11
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 11.06
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 10.93
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 10.87
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 10.85
ZIKV infection of monocytes activates inflammasome pathways 10.78
RNA m5C Methylation in breast cancer using MeRIP-Seq 10.77
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 10.73
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 10.73
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 10.68
The comparison of high-throughput single-cell RNA-seq methods 10.51
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 10.5
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 10.41
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 10.41
mRNA expression in human DAOY cells 10.34
Transcriptomic analysis of the HOTAIR-regulated genes 10.25
hnRNP C is a key regulator of protein synthesis in mitosis 10.16
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 10.1
Human cell line and subcutaneous tumor 10.09
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 10.08
Short and Long RNA sequencing of human mature erythrocytes 9.93
RNA-Seq analysis of breast cancer cells after shikonin treatment 9.75
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 9.73
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 9.69
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 9.65
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 9.5
Reassessment of Exosome Composition 9.48
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 9.45
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 9.44
Crizotinib v. DMSO in SW480 cells 9.4
Role of XRN2 ribonucleolytic activity in RNA metabolism 9.25
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 9.23
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 9.22
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 9.14
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 9.14
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 9.09
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 9.01
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 8.88
scRNASeq analysis of cycling cardiomyocytes 8.88
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 8.86
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 8.78
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 8.78
Gene expression profiling of leukemia cells following asparagine depletion 8.72
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 8.6
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 8.55
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 8.55
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 8.55
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 8.54
Lipid degradation promotes prostate cancer cell survival 8.53
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 8.51
MYC dependent mRNA translation shapes gene expression and cell biology 8.44
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 8.44
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 8.38
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 8.2
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 8.16
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 8.01
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 8.0
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 8.0
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 7.98
RNA-seq melanoma 7.96
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 7.86
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 7.84
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 7.82
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 7.76
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 7.7
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 7.68
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 7.59
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 7.59
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 7.54
HEK293 Heat-shock experiment 7.54
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 7.52
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 7.5
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 7.5
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 7.5
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 7.5
Biological effect of chronic mistranslation in mammalian cells 7.37
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 7.35
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 7.27
Global expression profiles in cardiac progenitor cells generated by ISX-9 7.23
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 7.23
U1 snRNP telescripting regulates size-function stratified human genome 7.22
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 7.17
Profiling of escape kinetics of viruses subjected to RNAi 7.06
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 7.06
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 7.01
Integrating single-cell transcriptomic data across different conditions, technologies, and species 6.96
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 6.96
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 6.92
SLAM-seq for K562 endogenous mRNA decay 6.9
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 6.88
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 6.85
Identification of renal resident macrophages across species 6.83
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 6.67
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 6.67
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 6.62
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 6.58
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 6.51
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 6.45
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 6.39
Comprehensive comparative analysis of 5’ end RNA sequencing methods 6.39
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 6.39
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 6.36
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 6.29
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 6.27
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 6.19
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 6.15
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 6.15
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 6.14
Illumina Total RNA-seq in HeLa 6.13
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 6.12
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 6.12
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 6.08
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 6.06
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 6.06
RNA sequencing of primary human platelets and in vitro cell lines 6.06
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 6.06
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 6.06
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 6.04
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 6.03
RNA-sequencing in irradiated and normal A549 cells. 6.01
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 6.01
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 5.98
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 5.98
RNA-seq of RKO cells with cTAZ KO or putback 5.98
The cohesin release factor WAPL restricts chromatin loop extension. 5.97
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 5.97
The transcriptome and chromatin accessbility landscape of mammalian germline 5.96
Small-molecule targeting of brachyury transcription factor addiction in chordoma 5.95
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 5.95
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 5.89
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 5.87
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 5.86
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 5.84
Transcriptome analysis of CNS leukemia 5.84
Human cells contain natural double-stranded RNAs with potential regulatory capacity 5.82
RNA-Seq with and without RNase treatment in PCa cell lines 5.81
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 5.8
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 5.79
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 5.71
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 5.66
circRNA profile in hypopharyngeal cancer 5.65
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 5.64
A single-cell transcriptome atlas of the human pancreas 5.63
RNA-sequencing 5.62
Identification of transcription start sites for human A549 cell line using ReCappable-seq 5.58
Exogenous rescue of KLHL9 in SF210 cell line 5.56
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 5.5
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 5.49
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 5.43
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 5.43
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 5.43
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 5.42
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 5.39
METTL3 and WTAP 5.36
Loss of CREBBP results in gene expression repression in lymphoma cells 5.34
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 5.34
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 5.27
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 5.26
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 5.19
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 5.18
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 5.13
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 5.13
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 5.12
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 5.11
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 5.11
K562 polyA RNA-Seq 5.08
Comparative Analysis of Cas9 Activators Across Multiple Species 4.93
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 4.91
RNAseq in Alzheimer's Disease patients 4.9
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 4.88
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 4.88
Transcriptomes of oxLDL exposed trained monocytes 4.86
oxLDL exposed trained monocytes 4.86
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 4.82
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 4.81
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 4.74
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 4.7
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 4.68
Defective structural RNA processing in relapsing-remitting multiple sclerosis 4.66
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 4.62
ADAR1-editing of cellular and measles virus-derived duplex RNA 4.62
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 4.62
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 4.54
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 4.54
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 4.53
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 4.49
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 4.49
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 4.44
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 4.42
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 4.36
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 4.36
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 4.33
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 4.29
RIG-I and MDA5 fRIP during KSHV lytic reactivation 4.28
Genome-wide discovery of human splicing branchpoints 4.27
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 4.21
Global response to chemotherapy-induced apoptosis 4.21
Identification of renal resident macrophages across species [C1] 4.2
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 4.13
Mapping interactions for the TNIP2 hub protein 4.08
Unique features and clinical importance of acute alloreactive immune responses 4.07
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 4.06
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 3.97
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 3.97
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 3.93
Transcriptome analysis of peripheral blood monocytes 3.82
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 3.79
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 3.78
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 3.78
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 3.75
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 3.75
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 3.71
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 3.71
Effect of BMP inhibition or stimulation of primary human keratinocytes 3.66
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 3.66
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 3.54
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 3.49
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 3.47
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 3.41
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 3.37
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 3.36
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.35
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.35
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 3.32
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 3.3
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 3.26
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 3.25
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 3.25
Systematic discovery of endogenous human ribonucleoprotein complexes 3.25
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 3.24
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 3.24
Transcriptome landscape of HeLa response upon triamcinolone acetonide 3.23
Gene expression profile of human placenta from T. Cruzi infected mothers 3.21
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 3.21
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 3.21
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 3.14
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 3.12
Determining mRNA half-lives on a transcriptome-wide scale 3.12
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 3.12
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 3.12
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 3.08
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 3.0
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 2.94
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 2.93
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 2.92
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 2.84
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 2.84
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 2.82
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 2.76
Regulatory network controlling tumor-promoting inflammation in human cancers 2.76
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 2.76
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 2.67
Determination of tRNA aminoacylation levels by high throughput sequencing 2.61
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 2.59
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 2.59
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 2.54
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 2.5
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 2.5
Transcriptional landscape changes during human embryonic stem cell derivation 2.48
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 2.43
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 2.42
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 2.39
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 2.36
Transcription elongation regulates genome 3D structure 2.31
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 2.31
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 2.31
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 2.28
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 2.27
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 2.26
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 2.26
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 2.25
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 2.24
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 2.22
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 2.21
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 2.21
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 2.21
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 2.19
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.18
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 2.17
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 2.15
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 2.15
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 2.15
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 2.15
High-resolution comparative analysis of great ape genomes 2.11
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 2.1
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 2.08
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 2.06
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 2.06
Generation and functional characterization of MDSC-like cells 2.02
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 1.96
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 1.92
Transcriptome-wide response to synthetic chromatin protein PcTF 1.91
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 1.9
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 1.86
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.84
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 1.83
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 1.82
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 1.81
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 1.72
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.72
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.67
Role of cervicovaginal microbiota in genital inflammation 1.67
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 1.66
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.64
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 1.61
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 1.59
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 1.53
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 1.53
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 1.51
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 1.5
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 1.49
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 1.49
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.48
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 1.47
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 1.47
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 1.45
Aging-associated patterns in the expression of human endogenous retroviruses 1.44
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 1.43
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 1.43
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.42
Metabolism as an early predictor of DPSCs aging 1.41
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 1.39
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 1.39
Alagille_Nodder 1.38
RNA Seq of Alagille liver biopsies 1.38
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 1.37
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 1.36
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 1.33
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 1.28
Aneuploidy-induced cellular stresses limit autophagic degradation. 1.23
Expression analysis of the TAF1 syndrome 1.18
IMP3 regulated gene expression in breast cancer cells 1.14
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 1.11
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 1.08
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 1.08
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 1.0
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.99
RNA-seq of primary patient AML samples 0.99
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 0.99
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.98
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.97
Dilated cardiomyopathy vs Myocarditis 0.97
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 0.96
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 0.96
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.95
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 0.92
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.91
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.9
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.9
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 0.88
Enhancer activation during EGF response 0.86
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 0.84
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.81
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.81
naive T cell heterogeneity after neonatal thymectomy 0.79
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.78
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.77
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.74
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 0.72
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.7
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 0.7
LINE-2 transposable elements are a source of functional human microRNAs and target sites 0.69
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 0.68
nELAVL HITS-CLIP in Alzheimer's Disease patients 0.67
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.65
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.65
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.65
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.63
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 0.62
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 0.57
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 0.57
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 0.54
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.53
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.52
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 0.51
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.51
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.48
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 0.47
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 0.47
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.45
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 0.45
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 0.44
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.42
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 0.39
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.39
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 0.38
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 0.38
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 0.36
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.32
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.26
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.24
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.22
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.2
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.2
MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma 0.19
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.17
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.14
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 0.13
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.09
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.08
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.07
RNA-seq data 0.07
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.05
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.05
Ribosome profiling upon inhibition of eIF4A 0.03
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.03
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.03
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.02
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation